Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03975387
Title Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astex Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

ASTX295

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST